Storia in 20 fonti

FDA approves new drug Rasonque to treat advanced pancreatic cancer

The US FDA on Wednesday approved Revolution Medicines' Rasonque for advanced pancreatic cancer, opening a new treatment option for patients with metastatic disease. A large trial found the once-daily…

Raccontata da

thestar.com+8 altre

Confronto fonti

6 prospettive sulla stessa storia

AI · summaries

france24.comStai leggendo3 h fa

FDA approves new drug Rasonque to treat advanced pancreatic cancer

originale

Timeline cronologica

martedì 25 agosto 2026·letemps.ch
L’Agence américaine du médicament approuve le Rasonque, traitement très prometteur contre le cancer du pancréas - Le Temps
Le médicament utilisant le daraxonrasib vient d’être autorisé sur le sol américain, pour un coût de traitement d’environ de 40 000 dollars par mois. Des essais cliniques…
mercoledì 26 agosto 2026·healio.com
Rasonque nabs FDA approval for previously treated metastatic pancreatic adenocarcinoma
The FDA has approved a first-in-class targeted therapy for adults with metastatic pancreatic adenocarcinoma. Daraxonrasib (Rasonque, Revolution Medicines), an RAS inhibitor,…

FDA approves new drug Rasonque to treat advanced pancreatic cancer

Confronto fonti

FDA approves new drug Rasonque to treat advanced pancreatic cancer

Timeline cronologica

L’Agence américaine du médicament approuve le Rasonque, traitement très prometteur contre le cancer du pancréas - Le Temps

Rasonque nabs FDA approval for previously treated metastatic pancreatic adenocarcinoma

FDA approves ‘game-changing’ pancreatic cancer drug

Revolution Medicines Wins FDA Nod for First-Of-Its-Kind Pancreatic Cancer Drug - Revolution Medicines (NA

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer

FDA approves new treatment for those with advanced pancreatic cancer - UPI.com

Revolution drug heralded as a pancreatic cancer breakthrough cleared by FDA

FDA Approves Pancreatic Cancer Drug That Could Double Survival Time—What To Know About Rasonque

'Grand Slam' Pancreatic Cancer Drug Wins FDA Approval

FDA approves landmark pancreatic cancer drug that's shown to improve survival

FDA approves new pancreatic cancer drug expected to usher in new era of treatment

FDA approves Revolution Medicines' pancreatic cancer drug, ushering in new era of KRAS therapy

FDA approves breakthrough drug to treat advanced pancreatic cancer

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | CNN

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug

FDA approves landmark pancreatic cancer drug that’s shown to improve survival

Tumore del pancreas, via libera negli Usa alla prima terapia mirata contro il gene killer RAS

Revolution Medicines gets FDA nod for targeted pancreatic cancer drug | The Jerusalem Post

New hope for pancreatic cancer patients after FDA approves drug to improve survival

EUA aprovam comprimido da Revolution Medicines para câncer de pâncreas

FDA approves ‘game-changing’ pancreatic cancer drug

FDA approves Revolution Medicines' daraxonrasib for pancreatic cancer

Revolution Medicines Wins FDA Nod for First-Of-Its-Kind Pancreatic Cancer Drug - Revolution Medicines (NA

Tumore al pancreas: nuovo trattamento in compresse raddoppia la sopravvivenza